Gilad Gershon
Vorstandsvorsitzender bei Tropic Biosciences UK Ltd.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Erez Vigodman | M | 64 |
Tropic Biosciences UK Ltd.
 Tropic Biosciences UK Ltd. Agricultural Commodities/MillingProcess Industries Tropic Biosciences UK Ltd. develops varieties of tropical crops by utilizing cutting-edge genome editing technologies. The company is headquartered in Norwich, the United Kingdom.
Laverock Therapeutics Ltd.
 Laverock Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Laverock Therapeutics Ltd. develops regenerative medicines for hypo immune pancreatic islet cells and oncology therapeutics. The CEO of the British company is David C. Venables. | - |
| David Venables | M | - |
Laverock Therapeutics Ltd.
Laverock Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Laverock Therapeutics Ltd. develops regenerative medicines for hypo immune pancreatic islet cells and oncology therapeutics. The CEO of the British company is David C. Venables. | - |
| Elsy Boglioli Hofman | F | 42 |
Laverock Therapeutics Ltd.
Laverock Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Laverock Therapeutics Ltd. develops regenerative medicines for hypo immune pancreatic islet cells and oncology therapeutics. The CEO of the British company is David C. Venables. | - |
| Eyal Maori | M | - |
Tropic Biosciences UK Ltd.
Tropic Biosciences UK Ltd. Agricultural Commodities/MillingProcess Industries Tropic Biosciences UK Ltd. develops varieties of tropical crops by utilizing cutting-edge genome editing technologies. The company is headquartered in Norwich, the United Kingdom. | - |
| Ofir Meir | M | - |
Tropic Biosciences UK Ltd.
Tropic Biosciences UK Ltd. Agricultural Commodities/MillingProcess Industries Tropic Biosciences UK Ltd. develops varieties of tropical crops by utilizing cutting-edge genome editing technologies. The company is headquartered in Norwich, the United Kingdom. | - |
| David Lawrence | M | 75 |
Tropic Biosciences UK Ltd.
Tropic Biosciences UK Ltd. Agricultural Commodities/MillingProcess Industries Tropic Biosciences UK Ltd. develops varieties of tropical crops by utilizing cutting-edge genome editing technologies. The company is headquartered in Norwich, the United Kingdom. | - |
| John Brown | M | 69 |
Laverock Therapeutics Ltd.
Laverock Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Laverock Therapeutics Ltd. develops regenerative medicines for hypo immune pancreatic islet cells and oncology therapeutics. The CEO of the British company is David C. Venables. | - |
| Ben Belldegrun | M | - |
Tropic Biosciences UK Ltd.
Tropic Biosciences UK Ltd. Agricultural Commodities/MillingProcess Industries Tropic Biosciences UK Ltd. develops varieties of tropical crops by utilizing cutting-edge genome editing technologies. The company is headquartered in Norwich, the United Kingdom. | - |
| David Charles Baulcombe | M | 72 |
Tropic Biosciences UK Ltd.
Tropic Biosciences UK Ltd. Agricultural Commodities/MillingProcess Industries Tropic Biosciences UK Ltd. develops varieties of tropical crops by utilizing cutting-edge genome editing technologies. The company is headquartered in Norwich, the United Kingdom. | - |
| Niccolo Manzoni | M | - |
Tropic Biosciences UK Ltd.
Tropic Biosciences UK Ltd. Agricultural Commodities/MillingProcess Industries Tropic Biosciences UK Ltd. develops varieties of tropical crops by utilizing cutting-edge genome editing technologies. The company is headquartered in Norwich, the United Kingdom. | - |
| Vincent Pétiard | M | - |
Tropic Biosciences UK Ltd.
Tropic Biosciences UK Ltd. Agricultural Commodities/MillingProcess Industries Tropic Biosciences UK Ltd. develops varieties of tropical crops by utilizing cutting-edge genome editing technologies. The company is headquartered in Norwich, the United Kingdom. | - |
| Tom Payne | M | - |
Laverock Therapeutics Ltd.
Laverock Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Laverock Therapeutics Ltd. develops regenerative medicines for hypo immune pancreatic islet cells and oncology therapeutics. The CEO of the British company is David C. Venables. | 3 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigtes Königreich | 12 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Gilad Gershon
- Persönliches Netzwerk
